Suicide is a major public health problem with B1 million victims each year worldwide. Up to 90% of adults who commit suicide have at least one psychiatric diagnosis such as major depression, bipolar disorder (BPD), schizophrenia (SZ), substance abuse or dependence. A question that has remained unanswered is whether the biological substrates of suicide are distinct from those of the psychiatric disorders in which it occurs. The serotonin 2C receptor (5-HT 2C R) has been implicated in depression and suicide. We, therefore, compared the frequencies of its mRNA editing variants in postmortem prefrontal cortical specimens from subjects who committed suicide or who died from other causes. All suicides occurred in the context of either SZ or BPD. The non-suicide cases included subjects with either SZ or BPD as well as subjects with no psychiatric diagnosis. We identified 5-HT 2C R mRNA editing variations that were associated with suicide but not with the comorbid psychiatric diagnoses, and were not influenced by demographic characteristics (age and sex) and alcohol or drug use. These variations consisted of a significant increase in the pool of mRNA variants (ACD and ABCD) that encode one of the most prevalent and highly edited isoforms of 5-HT 2C R, that is, VSV (Val156-Ser158-Val160). Because the VSV isoform of 5-HT 2C R exhibits low functional activity, an increase in its expression frequency may significantly influence the serotonergic regulation of the brain. Thus, at least in patients with SZ or BPD, overexpression of the VSV isoform in the prefrontal cortex may represent an additional risk factor for suicidal behavior.
Introduction
Suicide is the eleventh leading cause of death in the United States, accounting for 31 484 deaths in 2003 (the last data available), and contributing to the worldwide rate of approximately 1 million victims each year. The few studies that have been carried out suggest that one of the risk factors for suicide is a positive family history, and genetic modeling based on twin data estimate that 43% of the liability to suicide is attributable to additive genetic factors while the remaining 57% may be explained by environmental factors. 1 Up to 90% of adults who commit suicide have at least one DSM-IV psychiatric diagnosis. The majority of all suicides occur in relation to mood disorders (mainly major depressive disorder (MDD) and bipolar disorder (BPD)), but other psychiatric conditions such as schizophrenia (SZ), or substance abuse or dependence (including alcohol) also carry a significant risk for suicidal behavior. [2] [3] [4] [5] A question that has remained unanswered is whether the biological substrates predisposing to suicide are distinct from those of the psychiatric disorders in which it occurs. Even among the psychiatric populations at highest risk, suicide attempters constitute only a modest percentage. Moreover, most suicide attempters with depression tend to make multiple attempts while other individuals with the same severity of depression and similar treatments deny suicide attempts or ideation. 6 This suggests the existence of one or more vulnerability factor(s) that are not associated with comorbid psychiatric conditions. Since the demonstration of decreased levels of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of serotonin (5-HT), in the cerebrospinal fluid of a subgroup of depressed suicide attempters 30 years ago, 7 substantial additional evidence has accumulated that implicates the serotonergic system in both depression and suicide. 3, 4, [8] [9] [10] [11] Despite some inconsistencies across these studies and their inability to distinguish between neurobiological factors associated with suicide from those associated with the comorbid mental illness, these findings have raised the possibility of specific suicide-associated differences in various aspects of serotonergic function (for example, receptors, transporters, metabolic enzymes and their functional regulation). Recent studies have suggested abnormalities in mRNA editing of one of the serotonin receptors-2C (5-HT 2C R)-in depressed suicide victims. [12] [13] [14] RNA editing is a post-transcriptional-processing mechanism that results in an RNA sequence that is different from the one encoded by the genome, and thereby contributes to the diversity of gene products. There are different types of RNA-editing that either add or delete nucleotides, or that change one nucleotide into another. 15 The type of RNA editing that is most prevalent in higher eukaryotes converts adenosine (A) residues into inosine (I). 16, 17 A limited number of gene transcripts (B30), mostly those that encode channels and neurotransmitter receptors (for example, mammalian glutamate receptors, 5-HT 2C R, potassium channel Kv1.1, and Drosophila melanogaster sodium channel), have been identified to date. [18] [19] [20] [21] When editing occurs within a coding region, it has the potential to alter codon specificity because the ribosome reads inosine as guanosine (G) resulting in altered amino-acid sequence and potentially protein function. In most cases, edited and unedited versions of a given receptor/channel coexist expanding the functional range of the receptor population. A-to-I editing is catalyzed by enzymes termed adenosine deaminases that act on RNA (ADARs). Three different ADARs (ADAR1-3) have been identified in humans. ADAR1 and ADAR2 are expressed in all tissues and edit all known substrates of RNA editing including 5-HT 2C R 17, 22 ( Figure 1 ). ADAR3 is expressed exclusively in the brain; however, its catalytic substrate has not been identified. 23 5-HT 2C R mRNA is edited at five closely spaced adenosine residues (termed A, B, E, C and D editing sites), allowing for the generation of 32 different mRNA variants and 24 different protein isoforms of the receptor, ranging from the unedited Ile156-Asn158-Ile160 (INI) isoform to the fully edited Val156-Gly158-Val160 (VGV) isoform 18 ( Figure 1 ). Pharmacological studies have shown that the unedited isoform, INI, possesses considerable constitutive activity-an ability to spontaneously activate intracellular signaling pathways in the absence of agonist stimulation. 24 In contrast, when the 5-HT 2C R mRNA is edited, particularly at codon 158 (sites E and C), its constitutive activity is suppressed, and agonist potency is drastically reduced. For example, the edited isoform VSV (Val156-Ser158-Val160) has 4-fold reduced constitutive activity and 4-to 5-fold reduced potency to initiate intracellular signals relative to the unedited isoform INI. 18, [24] [25] [26] [27] [28] [29] [30] Thus, increased editing of the 5HT 2C R could lead to reduced responsiveness to serotonin and could represent one of the vulnerability factors that predispose some individuals to suicide.
Three different laboratories previously examined editing of the 5HT 2C R mRNA in the prefrontal cortex (PFC) of psychiatric patients including those who died from suicide. [12] [13] [14] Those studies reported highly variable results that in general indicated increased editing in psychiatric subjects who died from suicide (see Discussion section for details). However, those studies were not designed a priori to investigate differences between the editing variations associated with suicide as opposed to those associated with psychiatric conditions. In contrast, the studies reported here were conducted as a specific attempt to determine (using a larger sample size and a rigorous quantitative design) if editing of 5-HT 2C R mRNA in the PFC of suicide victims is different from that of people who died of non-suicide-related causes and, if so, whether any detected differences could be attributed to suicide per se as opposed to the comorbid psychiatric illness. To achieve this aim, we compared editing in specimens from psychiatric patients who committed suicide in the context of either SZ or BPD with specimens from subjects who died from causes other than suicide. The non-suicide cases included subjects with either SZ or BDP as well as subjects with no psychiatric history.
We found differences in the editing of the 5-HT 2C R mRNA in the PFC, which were present in only those BPD and SZ subjects who died from suicide. As a first step toward identifying the basis of these differences, we examined the mRNA expression of the receptor and the known enzymes responsible for editing in the same brain specimens. The results indicated that these factors were not altered in the PFC of suicide victims, and therefore did not contribute to or become affected by the observed differences in editing.
Materials and methods

Subjects
Specimens of total RNA extracted from the dorsolateral PFC (DLPFC) were obtained from the Stanley Foundation Array Collection (http://www.stanleyresearch.org/ programs/brain_collection.asp). These were derived from patients diagnosed with BPD, N = 34; SZ, N = 35 and from normal control subjects (NC; N = 35). General demographic information, history of alcohol and other substance abuse, cumulative neuroleptic exposure, prescribed antidepressant medications, and cause of death were documented for each subject ( Table 1) . Fifteen of 34 BPD patients and 7 of 35 SZ patients (total of 22 subjects) died from suicide.
Analysis of 5-HT 2C R editing cDNA synthesis and PCR. DNAse treatment and cDNA synthesis were performed as described. 31 To minimize the influence of erroneous amplification in a single PCR that could alter the proportions of differently edited mRNA variants, three independent PCRs were performed for each subject using 5-HT 2C R-F11 (TGTCCCTAGCCATTGCTGAT)/5-HT 2C R-R2 (ATC TTCATGATGGCCTTAGTCCG) primer-pair and a touch-down cycling program as described. 32 5-H T 2C R-R2 primer was designed within the area that contains all five editing sites and is deleted in the truncated mRNA splice variant. Therefore, only the fulllength cDNA was amplified using this primer pair. 32, 33 Cloning and sequencing. The PCR products of the three independent reactions generated for each subject were combined and resolved by agarose gel electrophoresis. A single DNA product of B250 bp was detected for each subject. The amplicon of this size was expected from the full-length 5-HT 2C R cDNA. The DNA product was gel-purified using a MinElute Gel Extraction Kit (Qiagen, Valencia, CA, USA), and Abbreviations: BPD, bipolar disorder subjects; NC, normal control subjects; PMI, postmortem interval; SZ, schizophrenia subjects. The information is presented in two-ways-by the manner of death (suicide or non-suicide) and by diagnosis. PMI, brain pH, and age at death data are shown as mean7s.e.m. a Twelve different antidepressant medications, including SSRIs and tricyclics, were prescribed alone or in combination.
Increased serotonin 2C receptor mRNA editing in suicide S Dracheva et al subcloned into a pCR4-TOPO vector (Invitrogen, Carlsbad, CA, USA). The recombinant plasmids were introduced into bacteria. From each bacterial transformation, which resulted in at least 400 clones expressing the recombinant plasmid DNA, 48 were picked randomly. Plasmid DNA was isolated, and the inserts of these plasmids were sequenced. The plasmid DNA insert from a single bacterial colony represented the edited region of an individual 5-HT 2C R mRNA transcript. After eliminating clones with ambiguous sequencing results (B6%), a total of 4709 clones (an average of 45 clones per subject) were analyzed.
Quantitative real-time PCR (qPCR)
Relative mRNA expression of HTR2C (5-HT 2C R), ADAR (ADAR1), ADARB1 (ADAR2) and ADARB2 (ADAR3) were measured by qPCR using an ABI Prism 7700 Sequence Detector (Applied Biosystems, Foster City, CA, USA), gene-specific TaqMan FAM/MGB assays (Applied Biosystems; Table 2 ), and a standard thermal cycling program as described. 31, 34 Only one cDNA was amplified in each PCR (monoplex). The reactions were run in triplicates for each sample. The relative expression level of the target transcripts was calculated as 2 DDCt (C t , threshold cycle; the amount of target, normalized to a calibrator and to an endogenous reference) as described in Livak and Schmittgen. 35 The expression levels of six different endogenous control genes were initially tested for each experimental sample and were ranked according to their expression stability using geNorm software (http://medgen.ugent.be/~jvdesomp/genorm/). Cyclophilin A (PPIA), b-glucuronidase (GUS), and b-2-microglobulin (B2M) were the most stable control genes, and the geometric mean of their expression values was used for normalization. 36 Statistical analysis Editing analysis. The parameters obtained in the study were: the editing efficiencies at each of the five sites, the 5-HT 2C R mRNA variants, and the predicted 5-HT 2C R protein isoforms. The data were analyzed using mixed-effects logistic regressions to adjust for multiple clones per subject using Supermix software. 37 The regression analysis was performed for each of the five editing sites (edited or not; yes/ no), for the six most frequent mRNA variants (present or not) and for the six most frequent protein isoforms (present or not) as a function of suicide (yes/no), BPD (yes/no) or SZ (yes/no). Interaction terms for suicide Â BPD and suicide Â SZ could be added to the analysis if significant (however none were significant). Analyses were performed twice; once with all subjects included, and then only for patients with a psychiatric diagnosis of BPD and SZ.
Gene-expression analysis. The differences in ADARs' and 5-HT 2C Rs' gene expression between subjects who committed suicide vs subjects who died of other causes and between subjects with different diagnostic groups (SZ, BPD or NC) were analyzed by analysis of variance and analysis of covariance.
Results
Analysis of RNA editing
Nucleotide sequence analysis was obtained for 4709 5-HT 2C R cDNA clones that were generated from the RNA specimens extracted from the DLPFC of 104 subjects. On average, 45 clones (range, 40-48) were analyzed for each subject. The value of each RNA editing parameter (observed RNA variants, predicted protein isoforms, editing efficiency at each site) was calculated as a proportion to the number of clones analyzed per subject. The mean values of these proportions (termed 'frequencies' for the RNA variants and protein isoforms, and 'efficiencies' for the levels of editing at each editing site) among the subjects within each of the study groups (entire cohort, non-suicide, suicide, BPD, SZ and NC) are shown in Tables 3-5. Thirty of the 32 possible 5-HT 2C R RNA variants were detected in the entire cohort. Only six of these variants, which contained editing combinations (Table 4) . In agreement with previous data, 32 the isoforms VSV and VNV (Val156-Asn158-Val160) were the most prevalent among the predicted 5-HT 2C R proteins (Table 4) . There were no significant differences between the frequencies of these two predicted isoforms (P = 0.25) in the entire cohort.
The potential covariates for the analysis were PMI, sample pH, age at death, sex, lifetime drug abuse, lifetime alcohol use and lifetime antipsychotic use. Effects of these covariates on the 17 variables studied were assessed by correlation analysis. Although only 5 of the 119 correlations were significant at the 0.05 level (pH at site E, lifetime alcohol use at site D, age at NONE and at INI, pH at VNV; r'sp0.245, P'sX0.012), the regression analysis was performed with and without the above-mentioned covariates.
The first set of regressions was performed using data obtained from all subjects (those with BPD, SZ and NCs; N = 104). When the analysis was performed with the covariates, the following editing sites, mRNA variants and predicted protein isoforms differed significantly between subjects who committed suicide relative to subjects who died of other causes: A (z = 2.26; P = 0.02), C (z = 2.40; P = 0.02) and D (z = 2.23; P = 0.03) ( Table 5) ; ABCD (z = 2.44; P = 0.01), and ACD (z = 2.42; P = 0.02) (Table 3, Figure  2 upper panel, left) and VSV (z = 3.41; P < 0.001) ( Table 4 , Figure 2 lower panel, left) . There was also a significant difference between persons with BPD versus NCs for VGV (z = À1.98; P = 0.05) ( Table 4 , Figure 2 lower panel, right). There were no significant changes attributable to SZ. Similar differences were observed when the regression analyses were performed without covariates. The data represent mean of the frequencies in each study group. Only the mRNA variants that were detected at B5% or greater frequency in at least one study group (shaded) were analyzed using mixed-effects logistic regressions. a Frequencies of ABCD and ACD were significantly increased in suicide victims compared to subjects who died of other causes (bolded).
The second set of regressions was performed after excluding NC subjects and using data obtained only from the subjects with a psychiatric diagnosis (BPD or SZ; N = 69). Statistical differences between the groups were similar to those described above. When psychiatric patients who committed suicide (N = 22) were compared to patients who died of other causes (N = 47) and when all of the above-mentioned covariates were used, the following variables differed significantly between groups: A (z = 2.05; P = 0.04), C (z = 2.11; P = 0.03), D (z = 2.30; P = 0.02), ABCD (z = 1.99; P = 0.05) (data not shown), and VSV (z = 2.69; P = 0.01) (Figure 3 upper panel) . The exclusion of covariates from the analysis did not affect the statistical outcome. There were no significant differences between persons with BPD and SZ in the analyses performed with or without the covariates (Figure 3 lower panel) .
Information was available on the antidepressant drugs that were prescribed to the psychiatric patients ( Table 1 ). The variety of antidepressants prescribed was too great for meaningful subgroup analysis. However, a known history of prescribed antidepressant of the suicide victims had no discernable impact on 5-HT 2C R editing in their DLPFC (Figure 3 upper  panel) . The data represent mean of the frequencies in each study group. Only the isoforms that had 5% or greater frequency in at least one study group (shaded) were analyzed using mixed-effects logistic regressions. a Frequency of VSV was significantly increased in suicide victims compared to subjects who died of other causes (bolded). b Frequency of VGV was significantly decreased in BPD patients compared to normal controls (bolded). The data represent mean of the efficiencies in each study group. a Efficiencies at sites A, C and D were significantly increased in suicide victims compared to subjects who died of other causes (bolded).
These data indicated a significant suicide-associated increase in editing efficiencies at A, C and D sites of the 5-HT 2C R mRNA and a significant increase in the pool of the mRNA variants (ACD and ABCD) that encode one of the most prevalent isoforms of 5-HT 2C R (VSV) in the PFC. The effects were not influenced by PMI, sample pH, age at death, sex, lifetime drug abuse, lifetime alcohol use, lifetime antipsychotic use, or prescribed antidepressant medications. There was a statistically significant decrease in the predicted frequency of the VGV isoform that is encoded by ABECD and AECD mRNA variants in patients with BPD compared to normal controls. However, because of the low overall expression of AECD and ABECD (3.7 and 3.0%, respectively) in the entire cohort (Table 3) , the significance of this finding, which is in the opposite direction to that observed in suicide, is not clear.
Gene-expression analysis
Relative mRNA expression of 5-HT 2C R, ADAR1, ADAR2 and ADAR3 was measured by qPCR using specific probes (Table 2 ). Separate analysis of variances for each mRNA did not indicate any significant suicide differences, any significant diagnosis differences, or any suicide Â diagnosis interactions (P'sX0.125). Excluding NCs did not substantively change the results. Similarly, separate analysis of covariances (using covariates mentioned above) did not yield any significant changes (data not shown).
Discussion
A question central to the etiology of suicide is whether its biological substrates are distinct from those associated with the psychiatric disorders in which it most frequently occurs. The present study provides evidence that they are. Specifically, we found 5-HT 2C R mRNA editing differences that were present in only those BPD and SZ subjects who died from suicide, and, thus, were associated with suicide but not with the comorbid psychiatric diagnoses. In addition, as was shown by robust statistical analyses, these variations were independent of demographic characteristics (for example, age, sex) and alcohol or drug use.
Although to date it has not been established whether all 5-HT 2C R mRNA editing variants are equally translated, the A-to-I editing of the receptor mRNA does not generate any 'rare' codons that are infrequently used in humans. Thus, assuming the equal translation, the suicide-associated variations in editing result in a significant (B35%) increase in the VSV isoform of the receptor. Because VSV has decreased basal activity and potency compared to the non-edited receptor, this finding implies reduced responsiveness of 5-HT 2C Rs to serotonin in the DLPFC of suicide victims. This is consistent with reported blunted metabolic and neuroendocrine responses to 5-HT 2C R agonist m-(chlorophenyl) piperazine (mCPP) and to fenfluramine (which effects 'net' serotonergic activity) in patients who have made suicide attempts and/or showed a pattern of impulsive/aggression, a trait that is highly correlated with suicide. [38] [39] [40] The mechanism by which this variation in serotonergic function influences suicidal behavior remains to be elucidated.
The present study is the first expressly designed and adequately powered study, which aimed to investigate whether the differences in 5-HT 2C R editing are associated with suicide rather with comorbid psychiatric illness. In addition, the large number (B45) of isolates sequenced per subject allowed for rigorous quantitation of suicide-associated variations in editing of the receptor. As was mentioned in the Introduction section, three different laboratories have previously reported changes in the 5-HT 2C R mRNA editing in the PFC of suicide victims.
12-14 Niswender et al. 12 looked at editing at the A, C and D sites in patients with SZ, MDD and in normal controls. No differences between diagnostic and control groups were found, but secondary analyses comparing suicides to all non-suicides or to non-suicides with SZ or MDD, identified increases in editing at the A site with a trend toward an increase in editing at the D site in the latter comparison. Iwamoto and Kato 14 compared A and D site editing in patients with BP, SZ or MDD to editing in controls. They reported trends for increased D site editing in MDD and increased A site editing in those patients who committed suicide. Gurevich et al. 13 compared suicides with a history of MDD to controls. That study had a very limited scope, but it analyzed all five editing sites. The authors observed an increase in editing at the E site, a trend towards an increase at the C site, and a decrease at the D site. Despite inconsistencies in the results of the prior studies (perhaps due to methodological constraints, post hoc comparisons or limited sample size and statistical power) a persistent observation was increased editing and a shift toward less responsive receptor isoforms in suicide subjects. This observation is in general agreement with the data obtained in the present study.
Strictly speaking, the evidence provided here can only suggest that increased 5-HT 2C R editing is an additional factor that heightens risk for suicide in psychiatric patients. To unconditionally demonstrate that the observed variations of 5-HT 2C R mRNA editing carry a risk for suicide that is independent of comorbid psychiatric illnesses would require an examination of subjects who died of suicide but did not meet the criteria for any prior psychiatric diagnosis. Such subjects were not available for us to study. Although no diagnosis by suicide interactions were statistically significant in the present study (see the Materials and methods section), we had power of 80% to detect between diagnosis differences of only 30% or greater in the effect of suicide on each editing parameter. Moreover, the effect of editing on suicide risk might also vary among psychiatric diagnoses other than BPD and SZ. Importantly, MDD remains to be investigated in this regard.
As with other complex moderately heritable traits, the liability to commit suicide is undoubtedly influenced by multiple genetic and non-genetic factors. The present study provides evidence that at least one of these factors is associated with the mRNA editing process. These data also revealed that the increased editing in suicide victims is not explained by altered mRNA expression of the editing substrate (5-HT 2C R mRNA) or of the known editing enzymes (ADARs). Differences may arise, however, from changes in the levels of ADAR proteins and/or their enzymatic activities, or from other factors that have been shown to be involved in regulating the editing process (for example, small nucleolus RNA HBII-52, RNA helicase A). 17, 41 Thus, a number of candidate targets can be identified for future investigation.
Recent data in mice suggested that the degree of the 5-HT 2C R RNA editing is sensitive to agonist levels. 42 Specifically, the frequencies of less edited or unedited isoforms with higher sensitivity to serotonin were increased when serotonin was depleted by as much as 80%. Conversely, a serotonin agonist increased the frequency of more edited isoforms that activate G-protein coupling less efficiently. Although the mechanism that links the level of serotonin to A-to-I editing of the 5-HT 2C R transcripts is not known, these animal data suggest that the increased editing detected in our study could be explained by a compensatory response to increased levels of serotonin in the PFC of suicides. This interpretation is in line with numerous reports of suicide being associated with S-allele of the serotonin transporter (5-HTT) promoter polymorphism. [43] [44] [45] The presence of this allele seems to reduce transcription efficiency for the 5-HTT gene leading to decreased 5-HTT expression and, consequently, decreased serotonin uptake and increased levels of serotonin. 46 The above suggestion, however, contradicts a more prominent hypothesis which regards the pathophysiology of suicide and depression as a deficiency in serotonergic neurotransmission caused by decreased levels of brain serotonin. 3, 4 The discrepancy can only be resolved by detailed investigation of the molecular mechanisms underlying the increased 5-HT 2C R editing in suicide, and by elucidation of the neural circuitry and signal transduction pathways that are involved in the regulation of suicidal behavior by 5-HT 2C R.
There is evidence that the salutary effects of selective serotonin reuptake inhibitors (SSRIs) is at least partially due to SSRI-induced increases in brain serotonin levels. 47 Because increased 5-HT 2C R editing can hamper the responsivity of this receptor subtype to serotonin, our findings suggest that antidepressant therapies, especially those that involve serotonin reuptake inhibition, may be less effective in blunting suicidal tendencies in a subpopulation of patients with an inherently high level of the VSV isoform. Moreover, the proportion of the VSV isoform could be additionally enhanced in these individuals during the initial stages of SSRI therapy as an adaptation to the augmented levels of serotonin in the synapse 22, 42 contributing to suicidality in this vulnerable subgroup of patients.
Because 5-HT 2C R is expressed only in the brain, the level of VSV cannot be assessed readily in living subjects; however, pharmacological manipulation of editing may hold promise as a potential preventive intervention. In addition to the PFC, 5-HT 2C R is expressed in other limbic structures such as nucleus accumbens, amygdala and hippocampus. 48 It is also expressed in the major monoamine synthesizing areas including the locus coeruleus, raphe nuclei, substantia nigra and ventral tegmental area where it is known to regulate dopamine release. [48] [49] [50] [51] Given the importance of these structures in modulating the emotional state, further investigation of the 5-HT 2C R mRNAediting status in these brain areas of suicide victims should be undertaken.
